Unknown

Dataset Information

0

Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease.


ABSTRACT: INTRODUCTION:Roux-en-Y gastric bypass surgery (RYGB) reduces albuminuria and the long-term incidence of end-stage renal disease in patients with obesity and diabetes. Preclinical modeling in experimental diabetic kidney disease demonstrates that improvements in glomerular structure likely underpin these findings. RESEARCH DESIGN AND METHODS:In adult male Zucker diabetic fatty (ZDF) rats, we profiled the effect of RYGB on weight and metabolic control as well biochemical, structural and ultrastructural indices of diabetic renal injury. Furthermore, we sequenced the renal cortical transcriptome in these rats and used bioinformatic pathway analyses to characterize the transcriptional alterations governing the renal reparative response to RYGB. RESULTS:In parallel with improvements in weight and metabolic control, RYGB reduced albuminuria, glomerulomegaly, podocyte stress and podocyte foot process effacement. Pathway analysis of RYGB-induced transcriptomic changes in the renal cortex highlighted correction of disease-associated alterations in fibrosis, inflammation and biological oxidation pathways. RYGB reversed disease-associated changes in the expression of transforming growth factor (TGF)-? superfamily genes that strongly correlated with improvements in structural measures of glomerulopathy. CONCLUSIONS:Improved glomerular structure in ZDF rats following RYGB is underpinned by pathway level changes, including interruption of the TGF-?-driven early profibrotic programme. Our data provide an important layer of experimental support for clinical evidence demonstrating that RYGB arrests renal damage in patients with obesity and type 2 diabetes.

SUBMITTER: Nair M 

PROVIDER: S-EPMC7398104 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease.

Nair Meera M   Martin William P WP   Zhernovkov Vadim V   Elliott Jessie A JA   Fearon Naomi N   Eckhardt Hans H   McCormack Janet J   Godson Catherine C   Brennan Eoin Patrick EP   Fandriks Lars L   Docherty Neil G NG   le Roux Carel W CW  

BMJ open diabetes research & care 20200701 1


<h4>Introduction</h4>Roux-en-Y gastric bypass surgery (RYGB) reduces albuminuria and the long-term incidence of end-stage renal disease in patients with obesity and diabetes. Preclinical modeling in experimental diabetic kidney disease demonstrates that improvements in glomerular structure likely underpin these findings.<h4>Research design and methods</h4>In adult male Zucker diabetic fatty (ZDF) rats, we profiled the effect of RYGB on weight and metabolic control as well biochemical, structural  ...[more]

Similar Datasets

2021-03-17 | GSE147706 | GEO
2020-02-10 | GSE126835 | GEO
2019-07-10 | GSE117085 | GEO
2023-11-01 | GSE161404 | GEO
| S-EPMC6281513 | biostudies-other
| S-EPMC5644872 | biostudies-literature
| S-EPMC5466471 | biostudies-literature
| PRJEB41988 | ENA
| S-EPMC4370587 | biostudies-literature
2020-11-18 | GSE161643 | GEO